This is the first study to provide a comprehensive evaluation of myocardial LV SGLT1 expression in context of the other two major myocardial glucose transporters, GLUT1 and GLUT4, in a relatively large number of myocardial LV human samples representing patients with end-stage HF. This evidence concerns the gene SLC2A4 and hydrops fetalis.